Potential confounding factors were adjusted using a multivariable Cox regression analysis, which included age, gender, tumor location, stage, ECOG PS, baseline albumin, baseline CA 19.9, year of diagnosis, and enrollment in the clinical trial. This evidence concerns the gene ALB and neoplasm.